Delivery Order SPE2DR25D1106-SPE2DR26FJF8C
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,388.40 to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Rhophylac 300 mcg/2 mL syringes. This firm fixed-price, competitively awarded contract calls for delivery to be completed by December 23, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,388.40 to AmerisourceBergen Drug Corp for Rhophylac 150mcg/ml (2 units), a specialty pharmaceutical product used in immunoprophylaxis. This competitive award, issued on December 30, 2025, represents a firm fixed-price delivery order with an ultimate completion date of December 31, 2025. The contract was not set aside for any special designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Rhophylac 300 mcg/2 mL syringes with a ceiling value of $1,720.80 and a firm fixed price structure. The contract is not set-aside and represents a competitive award to the pharmaceutical distributor. Performance will be completed by October 10, 2025, with fulfillment occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $1,434.00 delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for Rhophylac 300 micrograms/2 milliliter syringes. This competitively awarded, firm fixed-price contract has an ultimate completion date of November 25, 2025, and carries no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete purchase under AmerisourceBergen's...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,390.00 firm fixed-price contract is for the supply of 4567321981 ! RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a medical product used for healthcare purposes. The contract has an ultimate completion date of March 13, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML medical supplies. The $4,590.10 contract has a performance period through March 26, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and no set-aside designations were used. This delivery order is part of a larger indefinite delivery contract (IDC)...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract is for the supply of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a pharmaceutical product, with a potential value of $5,550.00 and a performance period through March 18, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA,...
- The Defense Logistics Agency awarded a delivery order valued at $1,969.36 to AmerisourceBergen Drug Corp for RhoGAM Ultra-Filtered Plus syringes, with performance to be completed by July 31, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 vehicle running through December 2026. No set-aside designation was applied to this...
- The Defense Logistics Agency awarded a delivery order valued at $1,386.04 to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/ML vials. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 15, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,906.60 for RhoGAM Ultra-Filtered Plus Syringes on November 20, 2025, with a completion date of December 12, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FJF8CDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,388.40 for Rhophylac 300 mcg/2 mL syringes under a firm fixed price contract. The award, issued December 31, 2025, with completion targeted for January 23, 2026, represents a non-competitive delivery against an existing contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's supply chain. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The prime IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications, vaccines, medical devices, and specialized healthcare commodities to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. The contract demonstrates AmerisourceBergen's established capability to fulfill federal medical supply requirements across multiple therapeutic domains through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 12/30/25 |